| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |